“…In these publications, sample sizes ranged from 96 to 1900 cases and from 101 to 1977 control subjects. Among the studies, 10 focused on gastric cancer [ 21 , 23 , 27 , 29 , 30 , 32 – 34 , 38 , 39 ], three focused on breast cancer [ 25 , 35 , 36 ], two focused on hepatocellular carcinoma [ 20 , 37 ], and one each focused on lung cancer [ 19 ], oral squamous cell carcinoma [ 22 ], salivary gland tumor [ 24 ], nasopharyngeal carcinoma [ 26 ], neuroblastoma [ 28 ], colorectal cancer [ 31 ], and prostate cancer [ 40 ]. Of the publications, 12 had quality scores higher than nine, and 10 had quality scores of no more than nine.…”